1. Aapro, M.S., Charrin, C., Krauer, F. and Delaloye, J.F. (1989). MG-CSF interferes with hydrocortisone in a clonogenic assay of ovarian cancer cells. In: C.H. Dittrich and M.S. Aapro (eds.) E.O.R.T.C. Clonogenic Assay Screening Group Report. Drugs, Cells and Cancer. (p. 4).
2. Alberts, D.S., Chen, H.S.G., Salmon, S.E., Surwitt, E.A., Young, L. and Moon, T.E. (1981). Chemotherapy of ovarian cancer directed by the human tumour stem cell assay. Cancer Chemother. Pharmacol. 6: 279–285.
3. Balconi, G., Broggini, M., Erba, E., D’Incalci, M., Colombo, N., Mangioni, C. and Bertolero, F. (1988). Human ovarian tumours in primary culture, growth, characterization and initial evaluation of the response to cis-platinum treatment in vitro. Int. J. Cancer 41: 809–818.
4. Benard, J., Da Silva, J. and Riou, G. (1983). Culture of clonogenic cells from various human tumours: Drug sensitivity assay. Eur. J. Cancer Clin. Oncol. 19: 65–72.
5. Benard, J., Da Silva, J., De Blois, M.C., Boyer, P., Duvillard, P., Chiric, E., and Riou, G. (1985). Characterization of a human ovarian adenocarcinoma line, IGROVI, in tissue culture and in nude mice. Cancer Res. 45: 4970–4979.